Two Sigma Securities »

Outlook Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $38k 36k 1.06

More positions owned by Two Sigma Securities

Ishares Core Msci Emkt (IEMG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Msci Acwi Etf (ACWI)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cme (CME)
Fox Corp Cl A Com (FOXA)
Home Depot (HD)
Ishares Tr Broad Usd High (USHY)
NVIDIA Corporation (NVDA)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Capital One Financial (COF)

View all positions for Two Sigma Securities

Top funds holding Outlook Therapeutics

Vanguard Group
Schonfeld Strategic Advisors
BlackRock
Geode Capital Management
Susquehanna International
UBS Group
Millennium Management
Commonwealth Equity Services
Simplex Trading
State Street Corporation
Scotia Capital
LVW Advisors
Citadel Advisors
Goldman Sachs Group
Jane Street

View all funds holding Outlook Therapeutics